Author:
Rai Rajani,Fatima Iram,Essel Katie,Chandra Vishal
Reference120 articles.
1. Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA, editors. SEER Cancer Statistics Review, 1975-2014. Bethesda: National Cancer Institute; 2017.
https://seer.cancer.gov/csr/1975_2014/
, based on November 2016 SEER data submission, posted to the SEER web site, April 2017. 1975–2014.
2. Micco M, et al. Imaging after treatment in uterine malignancies: spectrum of normal findings and most common complications. J Med Imaging Radiat Oncol. 2017;61(6):777–90.
3. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983;15(1):10–7.
4. Liu FS. Molecular carcinogenesis of endometrial cancer. Taiwan J Obstet Gynecol. 2007;46(1):26–32.
5. Sherman ME, Bur ME, Kurman RJ. p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis. Hum Pathol. 1995;26(11):1268–74.